Androcur 50 mg tablete
| Name | Androcur 50 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-843981106 |
| Active Substance | ciproteronacetat |
| Composition | jedna tableta sadrži 50 mg ciproteronacetata |
| Pharmaceutical Form | tableta |
| Manufacturer | Delpharm Lille S.A.S., Lys Lez Lannoy, Francuska;
Bayer Weimar GmbH und Co. KG., Weimar, Njemačka |
| Marketing Authorisation Holder | Bayer d.o.o., Radnička cesta 80, Zagreb |
| Marketing Authorisation Date | 03.02.2016 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/15-02/04 |
| Registration Number | 381-12-01/30-16-11 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | G03HA01 |
| Marketing status | stavljeno u promet |
| Shortage status | u tijeku |
| SmPC | download |
| PL | download |
Packaging
Direct Healthcare Professional Communication
| Name | Date | Download |
|---|---|---|
| Pismo zdravstvenim radnicima o ograničenjima primjene lijeka Androcur 50 mg tablete (ciproteronacetat) zbog rizika od meningeoma | 16.04.2020 | Bayer d.o.o. |
